NCT06362369 2026-04-13
A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
7 Hills Pharma, LLC
Phase 1/2 Recruiting
7 Hills Pharma, LLC
Memorial Sloan Kettering Cancer Center
Bristol-Myers Squibb
Cambridge University Hospitals NHS Foundation Trust